Introduction
The precise molecular mechanisms by which obesity influences neoplastic transformation, including colorectal cancer, continue to be one of the most perplexing and provocative questions in cancer research. In that context, how obesity influences canonical signaling pathways underlying tumorigenesis remains incompletely defined. Guanylyl cyclase C (GUCY2C), expressed selectively in intestinal epithelial cells, is the receptor for diarrheagenic bacterial heat-stable enterotoxins (STs) and the gut paracrine hormones, guanylin in colon and uroguanylin in small intestine (1) . This paracrine axis comprises a tumor suppressing circuit whose dysregulation universally characterizes colorectal carcinogenesis across species (2, 3) .
Indeed, guanylin is one of the most commonly lost gene products in colorectal tumorigenesis and its loss is one of the earliest events in intestinal transformation (2, 4, 5) . Loss of guanylin silences GUCY2C producing intestinal epithelial dysfunction disrupting homeostatic mechanisms organizing the crypt-villus axis including proliferation, DNA damage sensing and repair, and metabolic programming which contributes to tumorigenesis (6) (7) (8) . Here, we demonstrate that diet-induced obesity suppresses guanylin expression and silences GUCY2C through caloriedependent ER stress, contributing to tumorigenesis.
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Materials and Methods
Animal models C57BL/6 mice were purchased from NCI, while Balb/c (Stock Number 000651) and ob/ob (B6.Cg-Lep ob /J; Stock Number 000632) mice were purchased from JAX. Mice were acquired at 4 wks of age, acclimated for 2 wks, and fed Lean diet (LabDiet 5010; 3.0 kcal/g, 12.7% from fat and 58.5% from carbohydrate), HF diet (TestDiet 58Y1; 5.1 kcal/g, 61.6% from fat and 20.3% from carbohydrate) or HC diet (TestDiet 58Y2; 3.8 kcal/g, 10.2% from fat and 71.8% from carbohydrate) as indicated (Supplemental Table 1 ). Preliminary studies revealed that 4-6 weeks of a high fat diet was required to induce guanylin suppression. Gucy2c -/-mice, generated by inserting a neomycin resistance gene into the first exon, were bred, maintained, genotyped, and functionally characterized as described (7) . Sibling Gucy2c +/+ and Gucy2c -/-mice from five different Gucy2c +/-breeding pairs [(generation 16 by backcrossing to the C57BL/6J mice obtained from JAX (Stock Number 000664)] were used to generate mice for the experiments.
ROSA-STOP flox -Guca2a mice were generated by standard procedures in the Thomas Jefferson University transgenic mouse facility as described (9) . Expression of the GUCY2C ligand, guanylin (GUCA2A), is regulated by the ROSA26 promoter followed by a STOP codon flanked by two loxP sites upstream of full length Guca2a in ROSA-STOP flox -Guca2a mice (Fig. 4A) . Removal of the STOP codon by Cre recombinase activates constitutive transcription of Guca2a driven by the ROSA26 promoter (Fig. 4A) established in pilot studies to ensure at least ~50% tumor incidence in experimental cohorts.
Human tissues
Human distal colonic mucosal specimens were obtained from patients undergoing surgery under a protocol approved by the Thomas Jefferson University Institutional Review Board (control no. 01.0823). GUCA2A primer/probe for TaqMan® Gene Expression Assays (Mm00433863_m1, Hs 00157859_m1) in an ABI 7000 Sequence Detection System (Applied Biosystems) (7, 12) . Relative expression was calculated using the 2 -∆∆CT method utilizing villin1 (Life Technologies, Mm00494146_m1, Hs00200229_m1) as the internal control (9).
Cell culture and lentivirus infection
Immunostaining and immunofluorescence
Ki-67 served as a marker of proliferation, and immunohistochemistry was performed as described (7). Tissue specimens were deparaffinized and rehydrated, followed by heat-induced epitope retrieval (10 mmol/L citrate buffer, pH 6.0). After quenching with 3% H2O2 in TBS-T 
Growth curves and food intake
Five mice were housed together, each mouse was weighed weekly, and at least 20 mice from each cohort were followed. In the ob/ob restricted diet experiment, 3 mice were housed together and 6 mice from each cohort were weighed. For food intake, mice were separated into individual cages with wire-mesh floors, and given a pre-weighed amount of chow each day. All 11 | P a g e mice were given ad libitum access to water for the duration of the experiment. Food consumption was measured daily for 7 d to establish average food intake.
Statistical analyses
Minimum cohort sizes were computed using a power of 80% and a significance level of 0.05 (1-tailed test) employing a priori predictions of effect size and variance established by preliminary studies or literature review. Operators were blinded to sample identities for analyses.
Comparisons between two groups at single time points were analyzed by Student's t test, or by the Mann-Whitney test for measures not satisfying normality assumptions, and comparisons between >2 groups employed One-way ANOVA. All statistical tests were calculated using GraphPad Prism. Analyses represent mean  SEM of n=5, unless otherwise indicated, and * p<0.05, ** p<0.01, *** p<0.001, ****, p<0.0001. The association of hormone level with body mass index (BMI) in patients was completed using a linear mixed model incorporating heteroskedastic variances aligned with BMI category. A global test of mean differences across BMI levels was calculated, and differences in least squares means were used to assess differences for BMI groups in relation to lean individuals.
Results
There is an inverse relationship between guanylin mRNA expression in normal colonic epithelium and body mass index (BMI) in humans (p<0.001), and morbidly obese patients (BMI≥35 kg/m 2 ) exhibit an 80% decrease in guanylin mRNA expression compared to lean individuals (Fig. 1A) . Loss of guanylin mRNA expression in obesity recapitulated guanylin loss in colon tumors compared to matched normal adjacent tissues in patients (12) . Similarly, a high fat (HF) diet reduced guanylin mRNA expression in normal colon epithelia in mice ( (Fig. 1F) . Moreover, in an established model of colon cancer in obesity (14) , tumorigenesis induced by a HF diet associated with guanylin suppression mimicked that produced by genetic silencing of GUCY2C expression ( Fig. 1G-H) .
The established paradigm suggests that tumorigenesis associated with diet-induced obesity 13 | P a g e reflects reprogramming of the endocrine, adipokine, and inflammatory milieu (14-16).
However, a high carbohydrate (HC) diet which increased caloric intake ~40% (Supplemental Fig.   1A ) without producing weight gain (Supplemental Fig. 1B ) reduced colon expression of guanylin ( Fig. 2A-B) , induced epithelial dysfunction (Fig. 2B) , and amplified tumorigenesis (Fig. 2C ) that recapitulated the effects of a HF diet. Also, there is a phenotypic polymorphism in C57BL/6
mice in which about 20% consume excess calories (Supplemental Fig. 2A ) but resist dietinduced obesity (Supplemental Fig. 2B ) (17) . These mice, which remain lean on a HF diet, nevertheless lose guanylin mRNA (Supplemental Fig. 2C ) and protein expression associated with epithelial dysfunction marked by increased β-catenin that recapitulates those effects produced in obese mice (Fig. 2D) . Similarly, while Balb/c mice are genetically resistant to obesogenic diets and remain lean (Supplemental Fig. 3A-B ) (18), they lose guanylin expression on a HF diet (Supplemental Fig. 3C ). Further, ob/ob mice have a genetic defect in leptin expression producing obesity even on a calorie-restricted Lean diet (Supplemental Fig. 4A-B ) (19) . However, even in the context of obesity (Supplemental Fig. 4b ) consumption of a diet restricted to normal caloric intake did not reduce guanylin expression or increase β-catenin in ob/ob mice (Supplemental Fig. 4C; Fig. 2E ). Finally, obese wild type mice on a HF diet recover colonic guanylin expression, signaling, and β-catenin levels after 4 wks on a Lean diet (Fig. 2F ), although they remain persistently obese (Supplemental Fig. 5 ). Taken together, these observations demonstrate that guanylin suppression, GUCY2C silencing and epithelial dysfunction underlying intestinal tumorigenesis reflect the quantity of ingested calories, rather than the type of calories, or the endocrine, adipokine, and inflammatory milieu associated with obesity.
Ingesting excess calories induces endoplasmic reticulum (ER) stress associated with an unfolded
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protein response in extra-intestinal tissues (20, 21) . Here, HF or HC diets induced colon ER stress in mice, increasing canonical mRNA and protein markers of the unfolded protein response (Fig. 3A-B) (21, 22) . In that context, ER stress pharmacologically induced by tunicamycin or thapsigargin eliminated guanylin expression in Caco2 human colon cancer cells in vitro (Fig. 3C-D) . Similarly, intraperitoneal (IP) tunicamycin induced ER stress associated with loss of guanylin expression in mouse colon (Fig. 3E-F) . Further, ER stress genetically induced by eliminating expression of Xbp1 (10, 11), a key transcription factor mediating the unfolded protein response (21, 22) , almost completely abolished colon guanylin expression ( Fig. 3G-H) .
Conversely, blocking ER stress in mice on a HF diet by oral supplementation with the chemical chaperone taurodeoxycholic acid (TUDCA)(23) reconstituted colonic guanylin expression ( Fig.   3I-J) . Similarly, blocking the unfolded protein response by pharmacologic (Fig. 3K) or genetic ( Fig. 3L ) inhibition of PERK, an essential sensor of ER stress (22) , restored guanylin expression suppressed by tunicamycin in vitro. These observations highlight the role of ER stress and the associated unfolded protein response induced by ingested calories as one mechanism suppressing the expression of guanylin in obesity.
The present observations suggest that colon tumorigenesis associated with obesity reflects suppression of guanylin expression which silences the GUCY2C tumor suppressor by reversible calorie-dependent induction of ER stress and the unfolded protein response in colon epithelial cells. This hypothesis was directly tested employing a genetic mouse model in which enforced guanylin expression is induced selectively in intestinal epithelial cells (Fig. 4A)(7) . Induction of transgenic guanylin expression overcame endogenous guanylin suppression and GUCY2C
silencing, reconstituting VASP phosphorylation and normalizing β-catenin levels in mice on a HF
Discussion
While essential molecular details linking energy balance and cancer in any tissue have remained elusive, the present study establishes a direct link between signaling pathways underlying colon tumorigenesis and mechanisms directly contributing to obesity. In that context, GUCY2C is a tumor suppressing receptor whose silencing through loss of the paracrine hormone guanylin universally contributes to epithelial dysfunction underlying the initiation of sporadic colorectal cancer (1, 2, 4, 6-8, 12, 13). Although loss of guanylin mRNA and protein uniformly characterizes the earliest stages of intestinal tumorigenesis (2, 4, 12) , the precise molecular mechanisms modulating hormone expression remain undefined (1) . Here, we reveal that one mechanism contributing to guanylin suppression is the induction of ER stress and the unfolded protein response (20) (21) (22) . While a role for ER stress in intestinal tumorigenesis has been suggested (24), its role in regulating guanylyl cyclase signaling within, or outside, the intestine has not been recognized previously. The prevailing paradigm suggests that intestinal tumorigenesis related to obesity reflects dysregulation of the endocrine, adipokine, and inflammatory milieu characterizing the associated abnormal metabolic state (14) (15) (16) . Surprisingly, the present study reveals that hormone suppression reflects ER stress induced by hyperphagia and excess ingested calories (20, 21) , rather than the abnormal metabolic state produced by obesity. It is tempting to speculate that caloric suppression of guanylin expression, silencing GUCY2C, 
